News
bioMérieux, a world leader in the field of in vitro diagnostics, signed in November 2024 a Sale and Purchase Agreement (SPA) to acquire Neoprospecta. This company, based in Florianopolis, Brazil, develops and markets innovative user-friendly data and genomics solutions for augmenting quality assurance programs and improve microbiological risk prevention in food and pharma industries.
Swipe to discover more
-
Third-Quarter 2024 Business Review
bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the nine months ended September 30, 2024: Consolidated sales amounted to €2,871 million, representing an organic growth of +10.3% at constant exchange rates and scope of consolidation. -
Advancing Antimicrobial Stewardship in Emergency Care: how diagnostics can change the game.
Antimicrobial resistance (AMR) has been identified as an increasing threat to modern medicine, leading to higher treatment costs and increased morbidity and mortality.1 The misuse of broad-spectrum antibiotics is a major contributor to the rise of AMR — particularly in emergency care, where studies have estimated that 40% to 60% of antibiotics are inappropriately prescribed.2 To understand the cause of this disparity, it is important to provide context on the many unique facets of the emergency department, while exploring how comprehensive antimicrobial stewardship could improve prescribing practices. -
Canada's First Center of Excellence in the Fight Against Antimicrobial Resistance
On November 11, 2024, the Université de Sherbrooke (UdeS), the Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre hospitalier universitaire de Sherbrooke (CIUSSS de l'Estrie - CHUS) and bioMérieux, a world leader in the field of in vitro diagnostics, announce a three-year agreement to create a Canadian center of excellence dedicated to the fight against antimicrobial resistance and antibiotic stewardship.
Enabling Decision-Making
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19